Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 10.03.2026
MARCA by BolognaFiere & ADM
MARCA by BolognaFiere & ADM confirms its role as the global reference point for a category redefining retail strategy worldwide.
Next stop: MARCA Poland, April 21-22.
BOLOGNA, Italy, March 10, 2026 /PRNewswire/ -- The 22nd edition of MARCA by BolognaFiere & ADM delivered its strongest results o [ … ]
Tue, 10.03.2026
Cognizant
TEANECK, N.J., March 10, 2026 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) released new research showing that companies pursuing AI adoption overwhelmingly prefer IT services firms - such as "AI Builder" firms, a new services model defined by designing and building custom, full stack AI solutions - to deliver real enterprise value from AI.
The research [ … ]
Tue, 10.03.2026
Vingroup
EQS Newswire / 10/03/2026 / 16:30 CET/CEST
HANOI, VIETNAM - Media OutReach Newswire - 10 March 2026 - Amid volatility in global fuel prices, Vingroup has announced the launch of a special "Trade Gas for Electric" program in Vietnam, India, Indonesia, and the Philippines. The program offers an additional 3% discount on VinFast cars and 5% disc [ … ]
Tue, 10.03.2026
Skyhawk Therapeutics
Industry veteran brings more than 30 years of experience launching therapies for neurological diseases, including Huntington's disease, and will prepare Skyhawk for the launch of SKY-0515 as early as 2027.BOSTON, March 10, 2026 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapi [ … ]
Tue, 10.03.2026
CK Life Sciences Int’l., (Holdings) Inc.
EQS Newswire / 10/03/2026 / 12:45 CET/CEST
HONG KONG SAR - Media OutReach Newswire - 10 March 2026 - CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences" or the "Company", Stock Code: 0775) today announced the establishment of Sequencio Therapeutics ("Sequencio"), a wholly-owned subsidiary dedicated to advancing the Company's therapeut [ … ]
Tue, 10.03.2026
Immunic AG
Immunic Announces Grant of Key European PatentProtecting Relevant Dosing Regimens for Vidofludimus Calcium
– Patent Covers Label-Mandated Dosing Scheme Across All Indications, Including Multiple Sclerosis; Previously Granted by the USPTO in 2023 –
– Broad Protection Extends to All Forms of Vidofludimus, Including Its Salts, Solvates and Free Aci [ … ]
Tue, 10.03.2026
Glasswall
New AI-powered Threat Prediction Gives Security Teams Visibility Into Unknown and Zero-Day File ThreatsWASHINGTON, March 10, 2026 /PRNewswire/ -- Glasswall, an industry-leading provider of intelligent Zero Trust file protection solutions in both the business-to-government (B2G) and business-to-business (B2B) sectors, has today announced the launch [ … ]
Tue, 10.03.2026
ICMM
New global dataset puts mining and metals emissions in perspective as demand for energy transition minerals growsLONDON, March 10, 2026 /PRNewswire/ -- Today, ICMM publishes its new Global Mining & Metals Greenhouse Gas (GHG) Emissions Dataset, alongside an insights report that provides the most comprehensive, up-to-date picture of how the mini [ … ]
Tue, 10.03.2026
q.beyond AG
Exchange of q.beyond shares at a ratio of 5:1
q.beyond’s shares will be traded under ISIN DE000A41YDG0 starting Thursday, 12 March 2026
First share buybacks expected to be possible from mid-August 2026
Cologne, 10 March 2026. Starting Thursday, 12 March 2026, shares in IT service provider q.beyond will be listed under a new ISIN and, due to the r [ … ]
Tue, 10.03.2026
Cantourage Group SE
Company Name:
Cantourage Group SE
ISIN:
DE000A3DSV01
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 10
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Valuation remains de-coupled from operationsConsolidated FY24 figures finally out - no surprises, sentiment overhang li [ … ]
